Connecting the dots from Toll-like receptors to innate immune cells and inflammatory bowel disease

Journal of Clinical Investigation

Volumn 111, Issue 9, 2003, Pages 1284-1286

  Boone, David L ^a   Ma, Averil ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; INTERLEUKIN 10; PREDNISONE; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

CYTOKINE PRODUCTION; ENTERITIS; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOPATHOLOGY; INFLAMMATION; NOTE; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR BINDING;

EID: 0038665421     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI18545     Document Type: Note

References (14)

1. Fiorentino, D.F., Bond, M.W., and Mosmann, T.R. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081-2095.
2. Moore, K.W., de Waal Malefyt, R., Coffman, R.L., and O'Garra, A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683-765.
3. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., and Muller, W. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:263-274.
4. -/-) mice and intestinal inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 278:G829-G833.
5. Sellon, R.K., et al. 1998. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66:5224-5231.
6. Takeda, K., et al. 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity. 10:39-49.
7. Kobayashi, M., et al. 2003. Toll-like receptordependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J. Clin. Invest. 111:1297-1308. doi:10.1172/JCI200317085.
8. Oppmann, B., et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 13:715-725.
9. Cua, D.J., et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 421:744-748.
10. Janeway, C.A., Jr., and Medzhitov, R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216.
11. van Deventer, S.J., Elson, C.O., and Fedorak, R.N. 1997. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. Gastroenterology. 113:383-389.
12. Fedorak, R.N., et al. 2000. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology. 119:1473-1482.
13. Schreiber, S., et al. 2000. Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. Gastroenterology. 119:1461-1472.
14. Madsen, K. 2002. Combining T cells and IL-10: a new therapy for Crohn's disease? Gastroenterology. 123:2140-2144.